Exela Sodium Bicarbonate Injection Recalled for Sterility Assurance Failure
Exela Pharma Sciences is recalling 8.4% Sodium Bicarbonate Injection due to lack of assurance of sterility. The affected lot (C0001088/P0001317, expiring 08/2023) was distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II drug recall involving a sterile injectable product where sterility cannot be assured. A non-sterile injection carries inherent risk of serious infection and patient harm. Although no illnesses or deaths are reported in the source text, the classification and nature of the defect (compromised sterility of an injection product) warrants a Severe designation per the rubric.
Plain-English summary
Exela Pharma Sciences, LLC is recalling 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) in 50 mL vials. The recall affects 18,960 vials of lot number C0001088/P0001317 with an expiration date of 08/2023. The manufacturer has not provided assurance of sterility for this product.
The affected product was distributed nationwide within the United States. Healthcare providers and patients who have received this product should be aware of this recall.
Consumers and healthcare professionals with questions about this recall should contact the FDA or the manufacturer for further information and guidance on next steps.
The recalled product
- Product
- 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC., Lenoir, NC 28645, NDC 51754-5001-1
- Manufacturer
- Exela Pharma Sciences LLC
- Affected units
- 18,960
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: C0001088/P0001317
- Exp. Date 08/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Exela Pharma Sciences LLC
See all →- HighSodium bicarbonate injection recalled after arsenic exceeded impurity specification
FDA (Drugs) · 2025-09-17
- HighSodium Bicarbonate Injection Recalled Due to Sterility Assurance Issue
FDA (Drugs) · 2025-04-02
- SevereELCYS cysteine hydrochloride injection recalled for silicone contamination
FDA (Drugs) · 2023-11-29
- SevereMidazolam Injectable Recalled for Silicone Particulate Matter Contamination
FDA (Drugs) · 2023-11-29
- SevereFDA Recalls Sodium Bicarbonate Injection for Silicone Particulate Contamination
FDA (Drugs) · 2023-11-29
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22